Ocugen
-
{
- All
- News
-
Twitter Accounts Hyped Company Seeking Covid Vaccine Trials: Report
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
-
Bharat Biotech's Covaxin Approval Requested In US For Children Below 18
US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.
-
Bharat Biotech's US Partner Files Request With FDA For Covaxin Trials
Ocugen, Bharat Biotech's US partner for COVID-19 vaccine Covaxin, on Wednesday said it has submitted Investigational New Drug Application (IND) to the US Food and Drug Administration to conduct clinical trials.
-
Ocugen, Bharat Biotech To Co-Develop Covaxin For US: Report
Drug developer Ocugen Inc said on Tuesday it had partnered with Bharat Biotech to co-develop the Hyderabad-based company's COVID-19 vaccine candidate for the US market.
-
Twitter Accounts Hyped Company Seeking Covid Vaccine Trials: Report
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
-
Bharat Biotech's Covaxin Approval Requested In US For Children Below 18
US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.
-
Bharat Biotech's US Partner Files Request With FDA For Covaxin Trials
Ocugen, Bharat Biotech's US partner for COVID-19 vaccine Covaxin, on Wednesday said it has submitted Investigational New Drug Application (IND) to the US Food and Drug Administration to conduct clinical trials.
-
Ocugen, Bharat Biotech To Co-Develop Covaxin For US: Report
Drug developer Ocugen Inc said on Tuesday it had partnered with Bharat Biotech to co-develop the Hyderabad-based company's COVID-19 vaccine candidate for the US market.
